Relationship between comprehensive geriatric assessment and amyloid PET in older persons with MCI

Relationship between comprehensive geriatric assessment and amyloid PET in older persons with MCI

Abstract Background The association between amyloid deposition and cognitive, behavioral and physical performance in mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) has been poorly investigated, especially in older persons. Methods We studied the in vivo correlation between the amylo...

Full description

Bibliographic Details
Main Authors:	Fulvio Lauretani, Livia Ruffini, Maura Scarlattei, Marcello Maggio
Format:	Article
Language:	English
Published:	BMC 2020-09-01
Series:	BMC Geriatrics
Subjects:	Amyloid deposition MCI Alzheimer’s disease Positron emission tomography; motoric-cognitive risk syndrome Older persons Physical performance
Online Access:	http://link.springer.com/article/10.1186/s12877-020-01746-x

Similar Items

Added value of amyloid PET in individualized risk predictions for MCI patients
by: Ingrid S. vanMaurik, et al.
Published: (2019-12-01)

Accuracy of quantitative positron emission tomography assessment for differentiating cerebral age-related from pathological amyloid deposition: A preliminary report from a case-series study
by: Fulvio Lauretani, et al.
Published: (2018-01-01)

Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context
by: Gwendolien Vanderschaeghe, et al.
Published: (2017-12-01)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
by: Shannon L. Risacher, et al.
Published: (2019-12-01)

Incidence and predictors of mild cognitive impairment (MCI) within a multi-ethnic Asian populace: a community-based longitudinal study
by: Norlela Mohd Hussin, et al.
Published: (2019-08-01)

Safety and feasibility of a Dalcroze eurhythmics and a simple home exercise program among older adults with mild cognitive impairment (MCI) or mild dementia: the MOVE for your MIND pilot trial
by: Melanie Fischbacher, et al.
Published: (2020-07-01)

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
by: Fayçal Ben Bouallègue, et al.
Published: (2017-04-01)

Clinical Relevance of [<sup>18</sup>F]Florbetaben and [<sup>18</sup>F]FDG PET/CT Imaging on the Management of Patients with Dementia
by: Damiano Librizzi, et al.
Published: (2021-02-01)

Amyloid proteins and their role in multiple sclerosis. Considerations in the use of amyloid-PET imaging
by: Jordi A. eMatias-Guiu, et al.
Published: (2016-03-01)

Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques
by: Sanna Hellberg, et al.
Published: (2019-03-01)

Biomarker testing in MCI patients—deciding who to test
by: Ingrid S. van Maurik, et al.
Published: (2021-01-01)

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
by: Szu-Ying Lin, et al.
Published: (2019-12-01)

The differentiation of amnestic type MCI from the non-amnestic types by structural MRI
by: Gábor eCsukly, et al.
Published: (2016-03-01)

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
by: Daniela Bertens, et al.
Published: (2019-08-01)

The Use of EEG and ERPs in the Study of Aging and Mild Cognitive Impairment (MCI)
by: Kamal, Farooq
Published: (2021)

LIVING THE “FORGETTING EXPERIENCE:” AN EXPLORATORY OF THE LIVED EXPERIENCE OF MCI AMONG OLDER DISABLED VETERANS.
by: Schneider, Christine Marie
Published: (2020)

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease
by: Sanka Amadoru, et al.
Published: (2020-03-01)

Topographical Heterogeneity of Alzheimer’s Disease Based on MR Imaging, Tau PET, and Amyloid PET
by: Seun Jeon, et al.
Published: (2019-08-01)

Characterization of resting state activity in MCI individuals
by: Roberto Esposito, et al.
Published: (2013-08-01)

Characterization of [18F]flutemetamol binding properties : A β-amyloid PET imaging ligand
by: Heurling, Kerstin
Published: (2015)

TCMB’nin Para Politikası Duruşunun Alternatif Açıklaması: Parasal Durum Endeksi (MCI) (Alternative Explanations for the Monetary Stance of CBRT: Monetary Condition Index (MCI)
by: Bora SÜSLÜ, et al.
Published: (2012-01-01)

Possibility of Enlargement in Left Medial Temporal Areas Against Cerebral Amyloid Deposition Observed During Preclinical Stage
by: Imabayashi, E., et al.
Published: (2022)

Study on QSTR of Benzoic Acid Compounds with MCI
by: Fanhao Meng, et al.
Published: (2010-03-01)

Amyloid Load, Hippocampal Volume Loss, and Diffusion Tensor Imaging Changes in Early Phases of Brain Aging
by: Sven Haller, et al.
Published: (2019-11-01)

MOTORES DE COMBUSTIÓN INTERNA (MCI) OPERANDO CON MEZCLAS DE ETANOL GASOLINA: REVISIÓN
by: Alexander García Mariaca, et al.
Published: (2016-01-01)

Motores de combustión interna (MCI) operando con mezclas de etanol gasolina: revisión
by: Alexander García Mariaca, et al.
Published: (2016-04-01)

Staging of amyloid β, t‐tau, regional atrophy rates, and cognitive change in a nondemented cohort: Results of serial mediation analyses
by: Evan Fletcher, et al.
Published: (2018-01-01)

Correlates of Mild Cognitive Impairment of Community-Dwelling Older Adults in Wuhan, China
by: Xiaojun Liu, et al.
Published: (2018-11-01)

Beta-amyloid imaging in dementia
by: Kyung Ah Chun
Published: (2018-06-01)

Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia
by: Fati Nourhashemi, et al.
Published: (2018-04-01)

Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)
by: Andrea Brugnolo, et al.
Published: (2021-01-01)

The Aerobic and Cognitive Exercise Study (ACES) for Community-Dwelling Older Adults With or At-Risk for Mild Cognitive Impairment (MCI): Neuropsychological, Neurobiological and Neuroimaging Outcomes of a Randomized Clinical Trial
by: Cay Anderson-Hanley, et al.
Published: (2018-05-01)

Parkinson’s Disease–Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge
by: Davide Maria Cammisuli, et al.
Published: (2019-11-01)

Prevalence, incidence, and clinical impact of cognitive–motoric risk syndrome in Europe, USA, and Japan: facts and numbers update 2019
by: Marcello Maggio, et al.
Published: (2019-10-01)

Studies of serum amyloid P component (SAP) and antinuclear autoimmunity
by: Gillmore, Julian D.
Published: (2004)

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
by: Ye Tao, et al.
Published: (2020-04-01)

AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
by: Fei Gao, et al.
Published: (2020-01-01)

Accurate Transmission-Less Attenuation Correction Method for Amyloid-β Brain PET Using Deep Neural Network
by: Bo-Hye Choi, et al.
Published: (2021-07-01)

Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study
by: M. Pagani, et al.
Published: (2015-01-01)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
by: Elena Chipi, et al.
Published: (2019-08-01)

Cannot write session to /tmp/vufind_sessions/sess_1af6bqfsv5ocu4bbinkno8c409